| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |